Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1612
Full metadata record
DC FieldValueLanguage
dc.contributorGharipour, Mojganen_US
dc.contributorBehmanesh, Mehrdaden_US
dc.contributorSalehi, Mansooren_US
dc.contributorVaseghi, Golnazen_US
dc.contributorNezafati, Pouyaen_US
dc.contributorDianatkhah, Minooen_US
dc.contributorKhosravi, Elhamen_US
dc.contributorHosseini, Mohsenen_US
dc.contributorSadeghi, Masoumehen_US
dc.date.accessioned2020-11-23T06:12:05Z-
dc.date.available2020-11-23T06:12:05Z-
dc.date.issued2020-
dc.identifier.govdoc01568en_US
dc.identifier.urihttp://hdl.handle.net/11054/1612-
dc.description.abstractBackground Selenoproteins S (SELS or VIMP) may regulate cytokine production, and thus play a key role in the control of the inflammatory response. Methods This study consisted of 136 Iranian patients with cardiovascular disease (65 MetS-affected and 71 MetS un-affected individuals) in the selengene study. Expression of two variants of VIMP including VIMP I and II were analyzed in all subjects using Real-Time PCR and ELISA. Results The level of VIMP was lower in MetS+ compared to the MetS− subjects (p <0.05). We found no significant differences in quantitative expression of VIMP I and VIMP II in both groups. VIMP I reveal a reverse correlation with fasting blood sugar (FBS) (r = −0.45, p = 0.009). Moreover, SELS in protein level has negative correlation with WC (r = −0.171, p = 0.049) and positive correlation with HDL (r = 0.176, p = 0.046). Conclusions Our study suggests that VIMP in protein level is significantly lower in MetS and shows a reverse correlation with WC and positive correlation with HDL. Therefore, with regard to the functional role of this protein, it is possible to deduce that its lower expression leads to the higher secretion of unfolded proteins into the cytosol and outside the cell, where they cannot play their exact roles in the different pathways. Moreover, the reverse correlation of VIMP I with FBS suggests further consideration of VIMP and its variant VIMP I expression in regards to potential development of major CVD risk factors.en_US
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2020-10-13T00:37:24Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2020-11-23T06:12:05Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2020-11-23T06:12:05Z (GMT). No. of bitstreams: 0 Previous issue date: 2020en
dc.titleAssociation of Selenoprotein S Expression and its variants with metabolic syndrome in subjects with cardiovascular disease.en_US
dc.typeJournal Articleen_US
dc.type.specifiedArticleen_US
dc.bibliographicCitation.titleArchives of Medical Researchen_US
dc.bibliographicCitation.volume51en_US
dc.bibliographicCitation.issue6en_US
dc.bibliographicCitation.stpage535en_US
dc.bibliographicCitation.endpage541en_US
dc.subject.healththesaurusSELENOPROTEIN Sen_US
dc.subject.healththesaurusVARIANTSen_US
dc.subject.healththesaurusMETABOLIC SYNDROMEen_US
dc.subject.healththesaurusCARDIOVASCULAR DISEASEen_US
dc.identifier.doihttps://doi.org/10.1016/j.arcmed.2020.05.005en_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.